HOME >> BIOLOGY >> NEWS
Fertility experts urge clinics to consider natural cycle IVF instead of routine use of ovarian stimulants

A team of UK fertility experts wants IVF clinics to consider taking advantage of a womans natural cycle during infertility treatment instead of routinely using drugs to stimulate ovaries into producing extra eggs.

A study published today (Wednesday 31 January) in Europes leading reproductive medicine journal, Human Reproduction*, has found that for the majority of women the chances of pregnancy are just as good if doctors rely on the womans natural menstrual cycle.

The researchers view is that, in 60% to 70% of cases, a series of treatment cycles without using ovarian stimulation would be safer, less stressful and mean fewer multiple births. It also costs only a fifth of the price of current practice and would bring IVF within the reach of more childless couples worldwide and enable countries that state-fund IVF to help more women.

Dr Geeta Nargund and colleagues reached their conclusion following a study of 181 treatments in 52 women at the Assisted Conception Unit at Kings College Hospital, London. All the women had treatment based around their natural menstrual cycles.

They were found to have the same chance of having a baby after an average of three to four cycles of treatment as women undergoing conventional drug-stimulated treatment about a third (32% as against 34%).

The first test-tube baby born in 1978 in England was the result of normal menstrual cycle IVF treatment, but the practice was pretty well abandoned with the onset of extensive use of hormonal drugs to stimulate the ovaries into producing more eggs per cycle. This new study is the first to establish that basing treatment on a womans natural cycle can achieve comparable results with those of drug-stimulated cycles.

Dr Nargund, who now directs the fertility centre at St. Georges Hospital, London, said: "Weve demonstrated that it is an effective and potentially cost-effective option for certain groups. With a trend now to reducing the number of embryos transferred, ou
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-0-1536-772181
European Society for Human Reproduction and Embryology
30-Jan-2001


Page: 1 2 3

Related biology news :

1. Fertility study shows increased estrogen shortens window of implantation in mice
2. Fertility treatments increase incidence of twins at a cost
3. Discovery Of Mutation May Lead To Help For Male Fertility Problems
4. Research Suggests New Way To Gauge A Womans Fertility
5. Sperm Protein May Hold Clues For Fertility And Contraceptives
6. UB Fertility Researchers Find They Can Predict Pregnancy By Assessing Two Sperm Abnormalities
7. Poetically Timed With Spring, Budding Yeast Yield Possible Insight Into Male Fertility--And Infertility
8. Discovery By Fertility Specialist Offers Promise Of Reducing Multiple BirthsTied To Fertility Treatment
9. Leading experts in field of gene therapy to meet in Minneapolis
10. UC San Diego bioinformatics experts help reconstruct the genomic makeup of our ancestors
11. Veterinarians, wildlife experts applaud Chinas ban of wild bird trade

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... , ... September 30, 2019 ... ... disrupter and leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing ... product formulations related to “Ready-to-Print” (RTP) cellular product formats (patent number AU ...
(Date:9/25/2019)... ... September 25, 2019 , ... ... collaboration and dialogue, today announces its inaugural South CEO conference to ... Louisiana. , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives ...
(Date:9/24/2019)... ... September 24, 2019 , ... A-Alpha Bio , ... development, announced today that it has raised $2.8M from leading science-focused venture capital ... includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, Sahsen Ventures, Washington Research ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, ... to announce that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art ... new facility demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as ... Organization, with MRSA becoming one of the most serious concerns. Hong Kong cannot be ... of community-associated MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the ...
(Date:9/24/2019)... RAPID CITY, S.D. (PRWEB) , ... September 24, 2019 , ... ... million in funding for research led by faculty at South Dakota School of ... focuses on the tiny microbes that attach to surfaces to form a slimy and ...
(Date:9/17/2019)... ... 2019 , ... Geneticure, Inc., a Rochester Minnesota company developing ... U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) have issued ... hypertension treatment. , The patent applies to Geneticure’s first pharmacogenomics test, in ...
Breaking Biology Technology:
Cached News: